# Well-healthcare Technologies Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/well-healthcare-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.well-healthcare.com
- Total disclosed funding: $15M
- Latest round: Series A (Jul 29, 2021)
- Investors on record: 6

## About

Established in 2016 and based in Hangzhou, China, Well-healthcare Technologies Co. is a technology company that focuses on the research and development of monitoring systems and tumor liquid biopsy products. In 2018, the company established a subsidiary Zhejiang Huijian Zhipu Technology. In 2020, the company completed the pilot-scale development of Bio-pSi® bowel cancer peptide mapping test kit.

The company engages in the research and development of monitoring systems and tumor liquid biopsy products. Its main products include Bio-pSiTM mass spectrometry kit, Clin-MS Plat® high-throughput mass spectrometer and Huijian Zhiyun® AI diagnostic software, etc. The company has also established two technology platforms for high-throughput clinical mass spectrometry and artificial olfactory sensing systems based on semiconductor nanotechnology and artificial intelligence algorithms.

## Funding rounds

- Series A, Jul 29, 2021, $15M — Lotus Lake Capital, Thunderstorm VC, Zhuhai Longmen Capital Management, Guangzhou Tianhui Capital Management
- Series A, Jul 8, 2020 — Sinowisdom, Thunderstorm VC, SDIC Venture Capital

## Investors

- Sinowisdom (https://capitalatlas.ai/funds/sinowisdom) — Series A
- Thunderstorm VC (https://capitalatlas.ai/funds/thunderstorm-vc) — Series A
- SDIC Venture Capital (https://capitalatlas.ai/funds/sdic-venture-capital) — Series A
- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Series A
- Zhuhai Longmen Capital Management (https://capitalatlas.ai/funds/zhuhai-longmen-capital-management) — Series A
- Guangzhou Tianhui Capital Management — Series A